S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

GLYC GlycoMimetics Inc

0.318

-0.003 (-0.93%)

After Hours

Last Updated: 09:52:51

Delayed by 15 minutes

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

GlycoMimetics (NASDAQ:GLYC)
Historical Stock Chart
From Oct 2024 to Nov 2024

Click Here for more GlycoMimetics Charts.

GlycoMimetics (NASDAQ:GLYC)
Historical Stock Chart
From Nov 2023 to Nov 2024

Click Here for more GlycoMimetics Charts.

GlycoMimetics Inc News

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Thursday 28 November 2024 (4 hours ago) • Edgar (US Regulatory)

Crescent Biopharma to Present at Jefferies London Healthcare Conference 2024
Wednesday 13 November 2024 (2 weeks ago) • PR Newswire (US)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Friday 8 November 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 8 November 2024 (3 weeks ago) • Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Thursday 7 November 2024 (3 weeks ago) • Edgar (US Regulatory)

GlycoMimetics Announces New Uproleselan Clinical Data Will Be Presented at ASH Annual Meeting
Wednesday 6 November 2024 (3 weeks ago) • Business Wire

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
Tuesday 5 November 2024 (3 weeks ago) • Edgar (US Regulatory)

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Tuesday 5 November 2024 (3 weeks ago) • Edgar (US Regulatory)

Shares of Biotech Company Up Over 100% Premarket Following Merger & Funding Announcement
Wednesday 30 October 2024 (4 weeks ago) • AllPennyStocks.com

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Tuesday 29 October 2024 (4 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 29 October 2024 (4 weeks ago) • Edgar (US Regulatory)

GlycoMimetics Enters Into Acquisition Agreement With Crescent Biopharma
Tuesday 29 October 2024 (4 weeks ago) • Business Wire

More GlycoMimetics Inc News Articles

Ultimate Sports Entertai... (GM)

Euronext G TotalEnergies...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions